Donald Trump announced that he wanted to eliminate the HIV epidemic in the United States and fight cancer in children

President Donald Trump named Tuesday as a target finish in a decade with "the HIV epidemic" in your country, and promised to dedicate government funds for this purpose and the fight against cancer in children.

"No force in history has done more to promote the human condition than American freedom," Trump said.

"In recent years, we have made remarkable progress in the fight against HIV and AIDS, and scientific advances have led to a dream that was once out of reach." My budget will call for Democrats and Republicans In the next 10 years, we have made incredible and incredible progress, and together we will overcome AIDS in America and beyond. ", he said.

Approximately 38,000 people have contracted HIV in the United States in 2017, according to official statistics.

The number of infections has decreased over the years, but in some communities, like between homobaduals, the black people and the Hispanics, did not stop.

The president also asked lawmakers to join him in "the fight against cancer in children", and highlighted the story of one of his guests during the congressional speech, the ten-year-old girl Grace Eline, who has just been treated for a brain tumor.

"Many childhood cancers have been without new therapies for decades, and my budget proposal will ask Congress $ 500 million over the next decade to fund this vital life-saving research."he said.

Trump also said that your legislation "next big priority" will be to lower the prices of prescription drugs, and asked Congress to approve a bill in this regard.

"It is unacceptable that Americans pay much more than the inhabitants of other countries for identical drugs, often made in the same place, it is wrong, it is unfair and together we can there end.he condemned.

Last October Trump has tabled an ambitious proposal to lower the prices of some prescription drugsand deal with the imbalance between the costs of drugs in their country and in Europe.

The initiative aims to ensure that the agency in charge of the subsidized federal health insurance program for the elderly, called Medicare, can negotiate directly with pharmaceutical companies the prices of certain drugs based on the costs they have paid in other industrialized economies.